Effect of angiotensin II blockers on the prognosis of COVID-19: a toxicological view

Eur J Clin Microbiol Infect Dis. 2020 Oct;39(10):2001-2002. doi: 10.1007/s10096-020-03932-6. Epub 2020 Jun 16.
No abstract available

Publication types

  • Letter

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Antiviral Agents / therapeutic use*
  • Betacoronavirus / pathogenicity*
  • COVID-19
  • Coronavirus Infections / diagnostic imaging
  • Coronavirus Infections / drug therapy*
  • Cytokine Release Syndrome / diagnostic imaging
  • Cytokine Release Syndrome / prevention & control*
  • Host-Pathogen Interactions / drug effects
  • Humans
  • Losartan / therapeutic use
  • Pandemics
  • Pneumonia, Viral / diagnostic imaging
  • Pneumonia, Viral / drug therapy*
  • Prognosis
  • SARS-CoV-2
  • Severity of Illness Index
  • Telmisartan / therapeutic use
  • Tomography, X-Ray Computed
  • Valsartan / therapeutic use

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Antiviral Agents
  • Valsartan
  • Losartan
  • Telmisartan